SCHEMBL5286650

SCHEMBL5286650

CCN(Cc1ccc(Cl)cc1Cl)C[C@@H]1CCNC1

nearest known ligand 0.55

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 15/20 0.55
SLC6A4 P31645 15/20 0.55
CYP2D6 P10635 1/20 0.51
KCNH2 Q12809 1/20 0.51
SLC6A3 Q01959 4/20 0.49
NOS3 P29474 3/20 0.40
NOS1 P29475 3/20 0.40
NOS2 P35228 3/20 0.40
CHRM1 P11229 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4316564 1.00 SLC6A2 (0.55) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
Cadaverine Tartrate SCHEMBL4326826 0.90 SLC6A2 (0.54) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
SCHEMBL4324834 0.90 SLC6A2 (0.54) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
SCHEMBL4324698 0.90 SLC6A2 (0.51) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
SCHEMBL4327407 0.87 SLC6A4 (0.54) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
SCHEMBL4324930 0.87 SLC6A2 (0.61) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
SCHEMBL4317568 0.87 SLC6A2 (0.61) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
SCHEMBL4321553 0.84 SLC6A2 (0.52) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
Cadaverine Tartrate SCHEMBL4331820 0.82 SLC6A2 (0.53) SLC6A2SLC6A4CYP2D6KCNH2SLC6A3
SCHEMBL653143 0.82 MBTPS1 (0.52) SLC6A2SLC6A4CYP2D6SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756050-A1 AMINOMETHYL-AZACYCLE DERIVATIVES AS INHIBITORS OF MONOAMINE UPTAKE ELI LILLY AND COMPANY (US) 2007-02-28 EP disclosed
WO-2005118531-A1 AMINOMETHYL-AZACYCLE DERIVATIVES AS INHIBITORS OF MONOAMINE UPTAKE ELI LILLY AND COMPANY (US) 2005-12-15 WO disclosed